ClinicalTrials.gg
CompletedNCT07929142Updated Nov 10, 2026

Modified Surgical APGAR Score for Predicting Postoperative Delirium in Emergency Surgery

An observational study in Postoperative Delirium, Emergency Surgery, sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Observational

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
424
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational study aims to evaluate whether the modified Surgical APGAR Score (mSAS), calculated at the end of surgery from the lowest intraoperative heart rate, lowest mean arterial pressure, estimated blood loss, and operation time, can predict postoperative delirium in adult patients undergoing emergency surgery. Postoperative delirium is assessed with the CAM-ICU-7 on postoperative days 1, 2, 3, and 5. As a secondary aim, the relationship between postoperative delirium and major complications and mortality within 30 days after surgery is investigated.

Read the detailed description

Patients aged 18 years or older undergoing emergency surgery in any surgical specialty at Istanbul Prof. Dr. Cemil Tascioglu City Hospital were enrolled after written informed consent. Preoperative data (age, sex, ASA physical status, diagnosis, planned operation, surgical specialty, pre-induction Glasgow Coma Scale, and anesthesia technique) were recorded. Intraoperative heart rate and mean arterial pressure were obtained from anesthesia monitor trend data (heart rate at 1-minute intervals; mean arterial pressure at 1-minute intervals with invasive monitoring and 5-minute intervals with non-invasive monitoring). Estimated blood loss was calculated from suction canister contents, irrigation fluids, and blood-soaked gauze/sponges. Operation time was defined as the interval from induction of anesthesia to the end of surgery. The mSAS was calculated for each patient at the end of surgery.

Postoperative delirium and its severity were assessed by the investigator using the CAM-ICU-7 on postoperative days 1, 2, 3, and 5 in both ICU and ward patients, supported by observations of caregivers. The SOFA score was calculated from the worst values in the first 24 postoperative hours. Length of hospital stay, ICU admission and length of ICU stay, and 24th-hour Glasgow Coma Scale were recorded. Patients were followed for 30 days for major complications and mortality using hospital records, clinical notes, and telephone interviews after discharge.

02

Conditions studied

  • Postoperative Delirium, Emergency Surgery

Keywords

  • Surgical APGAR Score, CAM-ICU-7, Postoperative Complications, Risk Assessment
03

In context

Emergence Delirium

751 studies on the registry are indexed under Emergence Delirium; 262 are open to participants now.

This study's enrollment of 424 is above the median of 162 across 279 observational studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization is the lead sponsor of 87 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing emergency surgery in any surgical specialty at a tertiary city hospital in Istanbul, Türkiye.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Undergoing emergency surgery in any surgical specialty
  • Written

Exclusion criteria

Exclusion Criteria:

  • Hospitalization before the emergency surgery
  • Preoperative delirium
  • Use of antipsychotic medication
  • Diagnosis of dementia or Alzheimer's disease
  • Glasgow Coma Scale score below 8
  • Remaining intubated at the end of surgery
  • Inability to communicate
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
424 participants (actual)
Patient registry
No

Groups and cohorts

  • Adult emergency surgery patients

    Adults aged 18 years or older undergoing emergency surgery in any surgical specialty, in whom the modified Surgical APGAR Score was calculated at the end of surgery.

    Other: Modified Surgical APGAR Score assessment

Interventions

  • OtherModified Surgical APGAR Score assessment

    Calculation of the modified Surgical APGAR Score at the end of surgery using the lowest intraoperative heart rate, lowest mean arterial pressure, estimated blood loss, and operation time. No intervention is applied to the patient.

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative delirium

    Presence of postoperative delirium assessed with the Confusion Assessment Method for the Intensive Care Unit-7 (CAM-ICU-7), analyzed according to modified Surgical APGAR Score risk group.

    Time frame: Postoperative days 1, 2, 3, and 5

Secondary outcomes

  1. Severity of postoperative delirium

    CAM-ICU-7 total score (0-7); higher scores indicate more severe delirium.

    Time frame: Postoperative days 1, 2, 3, and 5

  2. Incidence of major postoperative complications

    Includes ICU admission, unplanned intubation, mechanical ventilation within 48 hours, unplanned reoperation, blood transfusion, surgical site infection, new-onset arrhythmia, myocardial infarction, pneumonia, sepsis/septic shock, bacteremia, acute kidney injury, pulmonary embolism, deep vein thrombosis, postoperative inotrope/vasopressor requirement, and cardiac arrest requiring CPR.

    Time frame: Within 30 days after surgery

  3. All-cause mortality

    Death from any cause.

    Time frame: Within 30 days after surgery

  4. Length of hospital stay

    Number of postoperative days in hospital.

    Time frame: Within 30 days after surgery

  5. Length of ICU stay

    Number of days in the intensive care unit.

    Time frame: Up to 30 days after surgery

  6. Duration of mechanical ventilation

    Number of days on mechanical ventilation.

    Time frame: Up to 30 days after surgery

  7. SOFA score

    Sequential Organ Failure Assessment score calculated from the worst values in the first 24 postoperative hours.

    Time frame: First 24 hours after surgery

07

Study locations

1 site
  • Istanbul Prof. Dr. Cemil Tascioglu City Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to institutional data protection regulations.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in May 2026, 11 months.

Of 181 non-industry observational studies under Emergence Delirium, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 11 months is below that.

Counting every sponsor, half of 181 studies reached it within 21 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 10, 2026
StartActual
May 12, 2025
Primary completionActual
May 1, 2026
CompletionActual
May 1, 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07929142
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Responsible party
Namigar Turgut (professor, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization) — Principal investigator
First posted
Nov 10, 2026
Start date
May 12, 2025
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Nov 10, 2026

Study contacts

Namigar turgut, Prof. Dr.
principal investigator · Istanbul Prof. Dr. Cemil Tascioglu City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion